tiprankstipranks
The Fly

Chemomab Therapeutics sees cash runway through 1Q26

Chemomab Therapeutics sees cash runway through 1Q26

Cash, cash equivalents and short-term bank deposits were $14.3 million as of December 31, 2024 compared to $19.9 million as of December 31, 2023. The current cash runway is expected to take the Company through the first quarter of 2026.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com